Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tenth-anniversary Glasgow Neuro Society 2022 conference proceedings.

ABSTRACT:

SUBMITTER: Ismahel H

PROVIDER: S-EPMC10559481 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Tenth-anniversary Glasgow Neuro Society 2022 conference proceedings.

Ismahel Hassan H Middleton Eilidh Elizabeth Stewart EES Evans Vivienne Eloise VE Chaudhary Attika A Shah Devansh Mitesh DM Gardee Ameerah A Bashir Aneesah Bashir Binti Azad ABBA Ball Emma Jane EJ Goonewardena Eranga E Anyaegbunam Gregory Kosisochukwu GK Al Salloum Laulwa Nasser LN Nelson-Hughes Meaghan Anna Grace MAG Minnis Meghan Lola ML Salim Omar O Hay Sophie Alexandra SA Cheng Yihui Y Ashraf Mohammad M Davidson Amy A Alakandy Likhith L Farias Ericka Mejia EM Keenlyside Andrew A Bharadwaj Hareesha Rishab HR Ueda Muzuki M Aziz Abdullah A Wong Yun Yan YY Jothi Agilandiswari Arumuga AA Hunter Mhairi M Banks Ptolemy Dw PD Chia Yu Ying YY Wellington Jack J Arora Amit A

Surgical neurology international 20230915

PMID: 37810290

Similar Datasets

InCoB celebrates its tenth anniversary as first joint conference with ISCB-Asia.

Project description:In 2009 the International Society for Computational Biology (ISCB) started to roll out regional bioinformatics conferences in Africa, Latin America and Asia. The open and competitive bid for the first meeting in Asia (ISCB-Asia) was awarded to Asia-Pacific Bioinformatics Network (APBioNet) which has been running the International Conference on Bioinformatics (InCoB) in the Asia-Pacific region since 2002. InCoB/ISCB-Asia 2011 is held from November 30 to December 2, 2011 in Kuala Lumpur, Malaysia. Of 104 manuscripts submitted to BMC Genomics and BMC Bioinformatics conference supplements, 49 (47.1%) were accepted. The strong showing of Asia among submissions (82.7%) and acceptances (81.6%) signals the success of this tenth InCoB anniversary meeting, and bodes well for the future of ISCB-Asia.

| S-EPMC3333168 | biostudies-literature

Proceedings of the Twentieth International Society of Sports Nutrition (ISSN) Conference and Expo.

Project description: Not available

| S-EPMC10388812 | biostudies-literature

Proceedings of the Eighteenth International Society of Sports Nutrition (ISSN) conference and expo.

Project description: Not available

| S-EPMC9310654 | biostudies-literature

Proceedings of the Nineteenth International Society of Sports Nutrition (ISSN) Conference and Expo.

Project description: Not available

| S-EPMC10078124 | biostudies-literature

Proceedings of Reanimation 2022, the French Intensive Care Society International Congress.

Project description: Not available

| S-EPMC9213104 | biostudies-literature

Intravenous rt-PA: a tenth anniversary reflection.

Project description:Clinical trials with rt-PA for treating AIS began 20 years ago in 1987, and the pivotal NINDS rt-PA Stroke Study was completed and published in 1995 with FDA approval in 1996, about 10 years ago. A large number of articles emanated from that study and have established the efficacy and generalizability of this treatment.Here we summarize the background of how the NINDS trial was developed and carried out and its main findings.The NINDS rt-PA Stroke Study resulted from preclincal and pilot studies and paralleled similar studies carried out around the world. Its positive results, compared with the other trials, probably were due to the early time window for treatment and well-organized clinical and statistical centers. Many controversies have surrounded its use since its approval. As a result of the NINDS rt-PA Stroke Study, many new approaches to thrombolytic therapy are under evaluation.The results of the NINDS rt-PA Stroke Study have affected the management of patients with acute stroke worldwide.

| S-EPMC2695447 | biostudies-other

Tenth Aquatic Models of Human Disease Conference 2022 Workshop Report: Aquatics Nutrition and Reference Diet Development.

Project description:Progress in biomedical research requires rigorous studies and reproducible outcomes. However, despite recent achievements, standard reference diets (SRDs) for aquatic model organisms, vital for supporting scientific rigor and reproducibility, are yet to be adopted. At this workshop, we presented findings from a 7-month diet test study, tightly coordinated and conducted across three aquatic research facilities: Zebrafish International Resource Center (ZIRC), Kent and Sharpton laboratories (Oregon State University), and Xiphophorus Genetic Stock Center (XGSC, Texas State University). We compared the impact of two commercial diets and a suggested zebrafish SRD on general fish husbandry, microbiome composition, and health in three fish species (zebrafish, Xiphophorus, and Medaka), and three zebrafish wild-type strains. We reported outcomes, gathered community feedback, and addressed the aquatic research community's need for SRD development. Discussions underscored the influence of diet on aquatic research variability, emphasizing the need for SRDs to control cross-experiment and cross-laboratory reproducibility. Species-specific reference diets are essential for model organism health and consistent research outcomes.

| S-EPMC10733753 | biostudies-literature

Conference Proceedings - 6th International Conference on Molecular Diagnostics and Biomarker Discovery (MDBD 2022): Building Resilience in Biomedical Research : Penang, Malaysia. 11-13 October 2022.

Project description: Not available

| S-EPMC9768775 | biostudies-literature

Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.

Project description:Successful drug development for people with cancers of the CNS has been challenging. There are multiple barriers to successful drug development including biological factors, rarity of the disease, and ineffective use of clinical trials. Based upon a series of presentations at the First Central Nervous System Clinical Trials Conference hosted by the American Society of Clinical Oncology and the Society for Neuro-Oncology, we provide an overview on drug development and novel trial designs in neuro-oncology. This Review discusses the challenges of therapeutic development in neuro-oncology and proposes strategies to improve the drug discovery process by enriching the pipeline of promising therapies, optimising trial design, incorporating biomarkers, using external data, and maximising efficacy and reproducibility of clinical trials.

| S-EPMC10401610 | biostudies-literature

Proceedings of AllerGen 2019 Research Conference

Project description: Not available

| S-EPMC6456938 | biostudies-literature